Mainstay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Mainstay Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,406	Closed	-$202K	–	124
2021 Q3	$202K	Sell	3,406 -19,711	-85%	-$1.3M	0.12%	94
2021 Q2	$1.54M	Sell	23,117 -567	-2%	-$37K	0.36%	37
2021 Q1	$1.5M	Sell	23,684 -1,451	-6%	-$90.3K	0.46%	37
2020 Q4	$1.56M	Sell	25,135 -3,181	-11%	-$196K	0.46%	39
2020 Q3	$1.71M	Sell	28,316 -1,816	-6%	-$109K	0.45%	23
2020 Q2	$1.77M	Sell	30,132 -1,646	-5%	-$98.5K	0.52%	23
2020 Q1	$1.76M	Sell	31,778 -4,135	-12%	-$253K	0.57%	18
2019 Q4	$2.31M	Buy	35,913 +3,726	+12%	+$213K	0.53%	20
2019 Q3	$1.63M	Buy	32,187 +1,929	+6%	+$90.7K	0.9%	28
2019 Q2	$1.37M	Buy	30,258 +4,296	+17%	+$200K	0.72%	37
2019 Q1	$1.24M	Sell	25,962 -2,670	-9%	-$133K	0.95%	31
2018 Q4	$1.46M	Sell	28,632 -3,006	-10%	-$162K	1.06%	17
2018 Q3	$1.96M	Sell	31,638 -1,573	-5%	-$93.3K	1.24%	12
2018 Q2	$1.84M	Sell	33,211 -2,363	-7%	-$128K	1.45%	17
2018 Q1	$2.25M	Sell	35,574 -621	-2%	-$39.9K	1.71%	9
2017 Q4	$2.22M	Buy	+36,195	New	+$2.26M	1.84%	10

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mainstay Capital Management's BMY Position: Q4 2021 in Review

Mainstay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 3,406 shares — an estimated $202K sold.

Mainstay Capital Management first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $2.31M in Q4 2019. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Mainstay Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Mainstay Capital Management sold 3,406 Bristol-Myers Squibb shares in Q4 2021, an estimated $202K.
Mainstay Capital Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
Mainstay Capital Management's Bristol-Myers Squibb position peaked at $2.31M in Q4 2019.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Mainstay Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.